Home068270 • KRX
add
Celltrion Inc
Previous close
₩182,800.00
Day range
₩181,600.00 - ₩182,700.00
Year range
₩144,615.31 - ₩203,500.00
Market cap
42.03T KRW
Avg Volume
792.09K
P/E ratio
50.58
Dividend yield
0.41%
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.03T | 16.67% |
Operating expense | 324.69B | 26.97% |
Net income | 331.35B | 287.12% |
Net profit margin | 32.20 | 231.62% |
Earnings per share | 1.51K | 297.76% |
EBITDA | 374.56B | 32.19% |
Effective tax rate | 12.18% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 953.61B | -18.93% |
Total assets | 21.08T | 3.81% |
Total liabilities | 4.24T | 29.39% |
Total equity | 16.84T | — |
Shares outstanding | 218.78M | — |
Price to book | 2.40 | — |
Return on assets | 3.62% | — |
Return on capital | 3.87% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 331.35B | 287.12% |
Cash from operations | 204.58B | -22.89% |
Cash from investing | -60.62B | 55.56% |
Cash from financing | 24.42B | 150.93% |
Net change in cash | 159.54B | 133.81% |
Free cash flow | 13.03B | -95.10% |
About
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Founded
2002
Website
Employees
1,074
